Bank of New York Mellon’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $140M | Buy |
1,312,756
+50,007
| +4% | +$6.06M | 0.02% | 532 |
|
|
2026
Q1 | $206M | Sell |
1,262,749
-127,293
| -9% | -$19.6M | 0.04% | 374 |
|
|
2025
Q4 | $242M | Buy |
1,390,042
+251,141
| +22% | +$45.8M | 0.04% | 324 |
|
|
2025
Q3 | $164M | Sell |
1,138,901
-58,572
| -5% | -$7.18M | 0.03% | 431 |
|
|
2025
Q2 | $121M | Buy |
1,197,473
+40,723
| +4% | +$3.11M | 0.02% | 554 |
|
|
2025
Q1 | $88.2M | Sell |
1,156,750
-281,716
| -20% | -$21.5M | 0.02% | 672 |
|
|
2024
Q4 | $99.3M | Sell |
1,438,466
-31,751
| -2% | -$2.29M | 0.02% | 644 |
|
|
2024
Q3 | $107M | Sell |
1,470,217
-337,153
| -19% | -$24.9M | 0.02% | 616 |
|
|
2024
Q2 | $121M | Sell |
1,807,370
-243,941
| -12% | -$9.46M | 0.02% | 546 |
|
|
2024
Q1 | $55.7M | Sell |
2,051,311
-305,551
| -13% | -$8.55M | 0.01% | 969 |
|
|
2023
Q4 | $73M | Sell |
2,356,862
-174,857
| -7% | -$4.53M | 0.01% | 822 |
|
|
2023
Q3 | $63.9M | Buy |
2,531,719
+83,255
| +3% | +$1.9M | 0.01% | 844 |
|
|
2023
Q2 | $51.7M | Sell |
2,448,464
-45,260
| -2% | -$859K | 0.01% | 998 |
|
|
2023
Q1 | $42.5M | Buy |
2,493,724
+1,138,343
| +84% | +$22.1M | 0.01% | 1109 |
|
|
2022
Q4 | $27.1M | Buy |
1,355,381
+413,799
| +44% | +$8M | 0.01% | 1376 |
|
|
2022
Q3 | $20.3M | Buy |
941,582
+440,161
| +88% | +$10.6M | ﹤0.01% | 1493 |
|
|
2022
Q2 | $9.89M | Sell |
501,421
-4,448
| -0.9% | -$93.2K | ﹤0.01% | 1942 |
|
|
2022
Q1 | $11.9M | Buy |
505,869
+1,717
| +0.3% | +$39.9K | ﹤0.01% | 1976 |
|
|
2021
Q4 | $13.7M | Buy |
504,152
+12,636
| +3% | +$361K | ﹤0.01% | 1931 |
|
|
2021
Q3 | $13.5M | Buy |
491,516
+47,558
| +11% | +$1.25M | ﹤0.01% | 1956 |
|
|
2021
Q2 | $12.6M | Buy |
443,958
+26,215
| +6% | +$778K | ﹤0.01% | 2000 |
|
|
2021
Q1 | $14.2M | Sell |
417,743
-15,020
| -3% | -$574K | ﹤0.01% | 1900 |
|
|
2020
Q4 | $14.4M | Sell |
432,763
-5,024
| -1% | -$184K | ﹤0.01% | 1810 |
|
|
2020
Q3 | $14.1M | Sell |
437,787
-10,647
| -2% | -$306K | ﹤0.01% | 1672 |
|
|
2020
Q2 | $12.3M | Buy |
448,434
+43,821
| +11% | +$1.04M | ﹤0.01% | 1710 |
|
|
2020
Q1 | $6.49M | Buy |
404,613
+4,744
| +1% | +$112K | ﹤0.01% | 1942 |
|
|
2019
Q4 | $9.55M | Buy |
399,869
+18,425
| +5% | +$375K | ﹤0.01% | 1994 |
|
|
2019
Q3 | $6.73M | Sell |
381,444
-5,559
| -1% | -$107K | ﹤0.01% | 2141 |
|
|
2019
Q2 | $9.91M | Buy |
387,003
+7,552
| +2% | +$210K | ﹤0.01% | 1970 |
|
|
2019
Q1 | $11M | Buy |
379,451
+10,522
| +3% | +$273K | ﹤0.01% | 1918 |
|
|
2018
Q4 | $4.84M | Buy |
368,929
+1,607
| +0.4% | +$25.6K | ﹤0.01% | 2315 |
|
|
2018
Q3 | $7.43M | Sell |
367,322
-2,161
| -0.6% | -$48.8K | ﹤0.01% | 2197 |
|
|
2018
Q2 | $8.74M | Sell |
369,483
-13,100
| -3% | -$337K | ﹤0.01% | 2090 |
|
|
2018
Q1 | $8.62M | Sell |
382,583
-37,637
| -9% | -$991K | ﹤0.01% | 2058 |
|
|
2017
Q4 | $13.1M | Buy |
420,220
+1,271
| +0.3% | +$37.5K | ﹤0.01% | 1853 |
|
|
2017
Q3 | $13.1M | Buy |
418,949
+88,076
| +27% | +$1.68M | ﹤0.01% | 1843 |
|
|
2017
Q2 | $5.68M | Buy |
330,873
+16,379
| +5% | +$280K | ﹤0.01% | 2264 |
|
|
2017
Q1 | $5.51M | Buy |
314,494
+12,336
| +4% | +$190K | ﹤0.01% | 2281 |
|
|
2016
Q4 | $4M | Buy |
302,158
+8,118
| +3% | +$111K | ﹤0.01% | 2447 |
|
|
2016
Q3 | $4.27M | Buy |
294,040
+6,649
| +2% | +$83.2K | ﹤0.01% | 2314 |
|
|
2016
Q2 | $2.83M | Buy |
287,391
+1,397
| +0.5% | +$16.3K | ﹤0.01% | 2516 |
|
|
2016
Q1 | $3.62M | Buy |
285,994
+9,601
| +3% | +$126K | ﹤0.01% | 2356 |
|
|
2015
Q4 | $5.02M | Buy |
276,393
+3,313
| +1% | +$58.4K | ﹤0.01% | 2211 |
|
|
2015
Q3 | $5.07M | Sell |
273,080
-58,926
| -18% | -$1.47M | ﹤0.01% | 2219 |
|
|
2015
Q2 | $8.11M | Buy |
332,006
+66,185
| +25% | +$1.5M | ﹤0.01% | 2077 |
|
|
2015
Q1 | $5.53M | Buy |
265,821
+14,444
| +6% | +$254K | ﹤0.01% | 2263 |
|
|
2014
Q4 | $3.89M | Sell |
251,377
-64,608
| -20% | -$917K | ﹤0.01% | 2442 |
|
|
2014
Q3 | $4.12M | Buy |
315,985
+48,888
| +18% | +$737K | ﹤0.01% | 2428 |
|
|
2014
Q2 | $5.34M | Buy |
267,097
+14,432
| +6% | +$214K | ﹤0.01% | 2292 |
|
|
2014
Q1 | $4.81M | Buy |
252,665
+39,442
| +18% | +$750K | ﹤0.01% | 2326 |
|
|
2013
Q4 | $3.63M | Sell |
213,223
-1,869
| -0.9% | -$28.6K | ﹤0.01% | 2497 |
|
|
2013
Q3 | $3.36M | Buy |
215,092
+46,733
| +28% | +$594K | ﹤0.01% | 2492 |
|
|
2013
Q2 | $2.01M | Buy |
+168,359
| New | +$1.72M | ﹤0.01% | 2786 |
|
Other funds holding INSM
Bank of New York Mellon's INSM Position: Q2 2026 in Review
Bank of New York Mellon increased its Insmed (INSM) stake by 4% in Q2 2026, buying an estimated $6.06M and bringing the position to 1,312,756 shares worth $140M. The position accounts for 0.02% of the portfolio, ranked #532.
Bank of New York Mellon first reported a position in INSM in Q2 2013 and has held it in 53 quarters since. The position peaked at $242M in Q4 2025. 382 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Bank of New York Mellon held 1,312,756 shares of Insmed worth $140M as of Q2 2026.
- Bank of New York Mellon bought 50,007 Insmed shares in Q2 2026, an estimated $6.06M.
- Insmed made up 0.02% of Bank of New York Mellon's portfolio in Q2 2026, its #532 holding.
- Bank of New York Mellon first reported a position in Insmed in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Insmed position peaked at $242M in Q4 2025.
- 382 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.